Neurological Disorder Drugs Market Size, Share Outlook 2033 Neurological Disorder Drugs Market to reach USD 66.4Bn in 2025, growing at 5.1% CAGR to USD 103.8Bn by 2033, driven by rising neurological disease cases globally. The Neurological Disorder Drugs Market is growing as the prevalence of neurological conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis, and migraine increases worldwide. Rising awareness of neurological health, expanding access to diagnostic services, and growing demand for effective treatment options are supporting market development. Pharmaceutical companies are investing in research and development to introduce innovative therapies that address disease progression, manage symptoms, and improve patients' quality of life. An aging global population and increasing recognition of neurological disorders are further contributing to demand for specialized medications. FULL REPORT - https://dimensionmarketresearch.com/report/neurological-disorder-drugs-market/